N4 Pharma Balance Sheet Health
Financial Health criteria checks 6/6
N4 Pharma has a total shareholder equity of £1.3M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £1.3M and £56.0K respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
| Interest coverage ratio | n/a |
| Cash | UK£1.20m |
| Equity | UK£1.28m |
| Total liabilities | UK£56.04k |
| Total assets | UK£1.34m |
Recent financial health updates
Companies Like N4 Pharma (LON:N4P) Are In A Position To Invest In Growth
Oct 11
Here's Why We're Not Too Worried About N4 Pharma's (LON:N4P) Cash Burn Situation
Jul 06Companies Like N4 Pharma (LON:N4P) Can Afford To Invest In Growth
Dec 07
Recent updates
Companies Like N4 Pharma (LON:N4P) Are In A Position To Invest In Growth
Oct 11Here's Why We're Not Too Worried About N4 Pharma's (LON:N4P) Cash Burn Situation
Jul 06Should Shareholders Have Second Thoughts About A Pay Rise For N4 Pharma Plc's (LON:N4P) CEO This Year?
Mar 18Here's What We Think About N4 Pharma's (LON:N4P) CEO Pay
Mar 01Companies Like N4 Pharma (LON:N4P) Can Afford To Invest In Growth
Dec 07Financial Position Analysis
Short Term Liabilities: N4P's short term assets (£1.3M) exceed its short term liabilities (£56.0K).
Long Term Liabilities: N4P has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: N4P is debt free.
Reducing Debt: N4P had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: N4P has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: N4P has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 0.5% each year.